Oraxol plus Encequidar (OPac plus E) vs IV paclitaxel (IVPac) in the treatment of patients with metastatic breast cancer (mBC) (Study KX-ORAX-001): Subgroup survival analysis of patients with hepatic dysfunction

Gerardo Umanzor,Hope S. Rugo, Francisco J. Barrios, R. H. Vasallo, Marco A. Chivalan,S. Bejarano, Julio Roberto Ramirez, Luis Fein, R. D. Kowalyszyn, D. L. Cutler,D. Kramer, H. Wang, R. M. F. Kwan

CANCER RESEARCH（2022）

引用 0|浏览2